FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084399 [Registered on: 08/04/2025] Trial Registered Prospectively
Last Modified On: 26/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Efficacy Of Aamar Patra Aamra Pushpa And Aamra Twak In Prameha (Diabetes Milletus 
Scientific Title of Study   Comparative Study Of Aamra (Mangifera indica)i.e. Aamra Pallav, Aamra Pushpa And Aamra Twak In Prameha With Special Reference To Diabetes Mellitus  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Swati Rammohan Tiwari 
Designation  Md (Ayu) Pg Scholar , Department Of Dravya Guna 
Affiliation  Maharashtra University Of Health Science , Nashik 
Address  11 Floor, Dravya Guna Department, K.G Mittal Ayurved College And Hospital , Netaji Subhash Road , Charni Road Mumbai

Mumbai
MAHARASHTRA
400002
India 
Phone  9869970800  
Fax    
Email  t.swati210@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Janhavi Rajesh Alwe 
Designation  Associate Professor 
Affiliation  Maharashtra University Of Health Science , Nashik 
Address  11th Fl, Dravya Guna Department, K.G Mittal Ayurved College And Hospital , Netaji Subhash Road , Charni Road Mumbai
11th Fl, Dravya Guna Department, K.G Mittal Ayurved College And Hospital , Netaji Subhash Road , Charni Road Mumbai
Mumbai
MAHARASHTRA
400002
India 
Phone  9324442463  
Fax    
Email  janhavialwe.JA@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr. Swati Rammohan Tiwari  
Designation  Pg Scholar , Department Of Dravya Guna  
Affiliation  Maharashtra University Of Health Science , Nashik 
Address  11th Fl, Dravya Guna Department, K.G Mittal Ayurved College And Hospital , Netaji Subhash Road , Charni Road Mumbai
11th Fl, Dravya Guna Department, K.G Mittal Ayurved College And Hospital , Netaji Subhash Road , Charni Road Mumbai
Mumbai
MAHARASHTRA
400002
India 
Phone  9869970800  
Fax    
Email  t.swati210@gmail.com  
 
Source of Monetary or Material Support  
K.G Mittal Ayurved College And Hospital 11th Floor , Dravya Guna Department ,K.G.Mittal Ayurved College And Hospital , Netaji Subhash Road, Charni Road Mumbai 400002  
 
Primary Sponsor  
Name  K.G.Mittal Ayurved College And Hospital  
Address  K.G.Mittal Ayurved College And Hospital , Netaji Subhash Road , Charni Road , Mumbai 400002 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL   NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSwati Tiwari  K. G Mittal Ayurved College And Hospital  11th Floor, Dravya Guna Department, K.G.Mittal Ayurved College, And Hospital, Netaji Subhash Road , Mumbai 400002
Mumbai
MAHARASHTRA 
9869970800

t.swati210@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, K.G Mittal Ayurved College   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: PRAMEHAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Aamra Pushpa, Reference: Adarsha Nighantu, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: od, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -Koshna jala), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Aamra Twak , Reference: Adarsha Nighantu, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: od, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -Koshna Jala), Additional Information: -
3Comparator ArmDrugClassical(1) Medicine Name: Aamra Patra, Reference: Adarsh Nighantu, Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: od, Bhaishajya Kal: Pragbhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1.Blood sugar level
Fasting 125mg/dl to 250mg/dl
post Prandial 150mg/dl&350mg/dl
2.HbA1C 6.5 %&10% 
 
ExclusionCriteria 
Details  1.Patient below 18YRS to Above 70 Yrs
2.Patient with type 1 diabetes Mellitus
3.Patient With Malignant Condition And Accelerated hypertension and Systematic Disease
4.Patient With Known Complication Of DM
5.Pregnant women and Lactating mother 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
efficacy of Aamra pallav(mangnifera indica linn)in reducing prameha /Diabetes Mellitus - parameter being blood sugar leval fasting and post prandial blood sugar level And hba1c
2.Efficacy of Aamra twak (mangnifera indica linn)in reducing prameha/ Diabetes Mellitus- parameter being blood sugar level (fasting and post prandial)and hba1c
3.Efficacy Aamra pushpa (Mangnifera indica linn.)in reducing prameha/Diabetes mellitus parameter being blood sugar level (fasting and post pradinal )and hba1c
4.Comparison between Aamra pallav , Aamra twak and Aamra pushpa churna in prameha  
FROM START AND AFTER 3 MONTH 
 
Secondary Outcome  
Outcome  TimePoints 
Authentication and standardization-analytical study
1.Pharmacognosy -macroscopic and microscopic studies
2. Phytochemical study
3.Standardisation of drugs
Literature study of aamra
Comparative study of aamra different part (prayoga anga)
ADR (adverse drugs rection ) if noted in patient  
90 days  
Authentication and standardization-analytical study
1.Pharmacognosy -macroscopic and microscopic studies
2. Phytochemical study
3.Standardisation of drugs
Literature study of aamra
Comparative study of aamra different part (prayoga anga)
ADR (adverse drugs rection ) if noted in patient  
90 days  
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   90 Patients presenting with symptoms of prameha will be selected by Randomized method (Alternate individual will be selected ). Selected individuals will be divided into three equal groups. Group will be divided into Group A , Group B  and Group C with 30 individuals in each groups . Symptoms of prameha will be assessed by using blood sugar level ,Hba1c and urine glucose .
Group A will be given Aamra patra churna 5 gram BD with koshna jala And Group B will be given Aamra twak churna 5gram BD with koshna jala  And Group C will be given Aamra pushpa churna 5gram BD with koshna jala Pragbhakta for 3 month for 3 drugs .After intervention , the measurement parameter and symptoms of prameha of Group A, Group B And Group C individual will be reassessed by using the subjective and objective criteria 

Generated data will be subjected to appropriate statistical test and conculsion will be drawn using statistical and observations found in study . 


the pharmacognostical study , physical analysis , chemical analysis of three drugs will be studied during the trial 
 
 
Close